Three years after undergoing gene therapy, his ‘last shot’ hit the target
Three years after undergoing gene therapy at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center to treat a life-threatening immune disorder, an Ohio college student is no longer thinking about his own “last shot” for health, but rather about medical school and “giving back.”
Alvin Powell
• harvard
Feb. 21, 2019 • ~17 min
Feb. 21, 2019 • ~17 min
/
1